No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes

Author(s): Weitao Zhou, Xiaoyong Li, Daochao Huang, Weihui Zhou, Tingyu Li, Weihong Song

Journal Name: Current Alzheimer Research

Volume 12 , Issue 1 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


It is reported that 7,8-dihydroxyflavone (DHF), a TrkB agonist, has beneficial effects on neuronal excitotoxicity, stroke, and Parkinson disease in animal models by enhancing axon regeneration, muscle reinnervation and neuromuscular transmission. The effect of DHF on AD neuropathology remains not well defined. In this study we examined whether DHF affects APP processing and cognitive functions in vitro and in vivo. We found that DHF had no significant effect on amyloid β precursor protein (APP), BACE1 and amyloid β protein (Aβ). DHF had little effect on APP processing in cell cultures. DHF treatment did not reduce the deposition of Aβ to form neuritic plaques in the brain of AD model mice APP23/PS45. Furthermore, DHF did not alleviate learning and memory impairments in the AD model mice. Our study suggest that further extensive and careful studies are warranted for considering DHF as a new therapeutic agent for reducing amyloid pathology and alleviating cognitive deficits for AD treatment.

Keywords: Aβ, Alzheimer’s disease, 7, 8-dihydroxyflavone, memory deficits.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [47 - 52]
Pages: 6
DOI: 10.2174/1567205012666141218124243

Article Metrics

PDF: 68